HomeENTX • NASDAQ
Entera Bio Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 42.00K | — |
Operating expense | 2.56M | 24.30% |
Net income | -2.57M | -27.27% |
Net profit margin | -6.11K | — |
Earnings per share | — | — |
EBITDA | -2.56M | -24.69% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.57M | 36.83% |
Total assets | 21.60M | 110.96% |
Total liabilities | 2.22M | 61.41% |
Total equity | 19.38M | — |
Shares outstanding | 45.42M | — |
Price to book | 4.60 | — |
Return on assets | -41.35% | — |
Return on capital | -45.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.57M | -27.27% |
Cash from operations | -1.40M | 24.60% |
Cash from investing | -8.00K | — |
Cash from financing | 13.34M | 44,356.67% |
Net change in cash | 11.93M | 750.93% |
Free cash flow | -9.49M | -743.69% |
Previous close
$1.98
Day range
$1.84 - $2.04
Year range
$1.41 - $2.79
Market cap
91.13M USD
Avg Volume
39.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Website
Employees
18
